- Sanofi (NASDAQ:SNY) has got one step closer to completing its acquisition of Kadmon Holdings (NASDAQ:KDMN). In a regulatory filing on Thursday, Kadmon (KDMN) said that the HSR waiting period in connection with the acquisition was expired on Oct. 20.
- As of the end of the period, the company or Sanofi (SNY) has not received a Form Letter from the Federal Trade Commission (FTC) paving the way for the deal to move forward.
- In early September, the French pharma giant announced an agreement to acquire Kadmon (KDMN) for $9.50/share in cash indicating $1.9B in equity value. The deal is expected to close in Q4 2021, subject to customary closing conditions.